Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis
PHASE1Not yet recruitingINTERVENTIONAL
Enrollment
6
Participants
Timeline
Start Date
April 30, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
December 31, 2026
Conditions
Radiation Proctitis
Interventions
DRUG
Mesenchymal Stem Cells (MSCs)
single dose injection (120 million cells)
All Listed Sponsors
lead
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
INDUSTRY
NCT06925607 - Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis | Biotech Hunter | Biotech Hunter